Quest Diagnostics Sees FY16 Results In Line With View

(RTTNews) - Quest Diagnostics Inc. (DGX) said that it expects adjusted earnings per share, excluding amortization expense, to be between $5.02 and $5.17. Revenues is expected to be between $7.52 billion and $7.59 billion, an increase of 1.5% to 2.5% over 2015 revenues on an equivalent basis. Analysts polled by Thomson Reuters expect the company to report earnings of $5.09 per share and revenues of $7.58 billion for fiscal year 2016. Analysts' estimates typically exclude special items.

Quest Diagnostics' Board of Directors authorized a 5% increase in its quarterly dividend from $0.38 to $0.40 per share, or $1.60 per share annually, payable on April 20, 2016, to shareholders of record of Quest Diagnostics common stock on April 6, 2016. The increase is the company's fifth dividend increase since 2011.